Abera Bioscience AB
556909-0904ActiveDeveloping next-generation nasal vaccines using modular OMV platform technology.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2012
- Grunnlagt
Nøkkelbeslutningstakere
Maria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
+3 flere kontakter i Funnelfeedr
Beskrivelse
Abera Bioscience AB is a Swedish biotechnology company specializing in the development of next-generation vaccines. They utilize a proprietary, modular Outer Membrane Vesicle (OMV) platform technology. This platform allows for rapid design and cost-effective production of vaccines that induce robust...
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556909090401
Beslutningstakere
7 kontakter i FunnelfeedrMaria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
Cristina Glad
Member of the Board
Fredrik Juserius
Member of the board
Harry Råstedt
Member of the board
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrNOVAVAX, INC.
Developing innovative protein-based vaccines using proprietary adjuvant technology.
Modus Therapeutics Holding AB
1–4 ansatteSwedish biotech developing sevuparin for severe inflammatory conditions.
Novavax AB
100–199 ansatteInnovating vaccines using proprietary technology platform and strategic partnerships.
SVANOVA AB
Developing innovative veterinary diagnostic solutions for animal health.
APTAMEDICA AB
Provides a real-time drug diagnostics platform for precision medicine.
Spørsmål om Abera Bioscience AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo